Moreover, more and more evidence has shown that MALAT-1 has potential application value in the clinical diagnosis of lung carcinoma, which suggests that MALAT-1 can be used as one of the indicators for the early NSCLC diagnosis [18, 19]. This evidence concerns the gene MALAT1 and non-small cell lung carcinoma.